Universitätsklinikum Augsburg

Quantitative analysis of submucosal excision depth in endoscopic resection for early Barrett's cancer (2021) Krause J, Roesch T, Steurer S, Clauditz T, Sehner S, Schumacher U, Neuhaus H, et al. Journal article Influence of Turkish origin on hematology reference intervals in the German population (2021) Mayr FX, Bertram A, Cario H, Frühwald MC, Groß HJ, Groening A, Grützner S, et al. Journal article Characteristics and Outcome of Patients with Acute Myeloid Leukemia and Trisomy 4 (2021) Kayser S, Martinez-Cuadron D, Hanoun M, Stoelzel F, Gil C, Reinhardt HC, Aguiar E, et al. Conference contribution Allogeneic Hematopoietic Cell Transplantation in Patients <= 60 Years with Intermediate-Risk Acute Myeloid Leukemia in First Remission - Results of the Randomized Etal-1 Trial- (2021) Bornhaeuser M, Schliemann C, Schetelig J, Rollig C, Kramer M, Glass B, Platzbecker U, et al. Conference contribution Final Induction Therapy Results of an Open Label Phase II Study Using Inotuzumab Ozogamicin for Induction Therapy, Followed By a Conventional Chemotherapy Based Consolidation and Maintenance Therapy in Patients Aged 56 Years and Older with Acute BLymphoblastic Leukemia (INITIAL-1 trial) (2021) Stelljes M, Alakel N, Waesch R, Scholl S, Nachtkamp K, Rank A, Haenel M, et al. Conference contribution Emergency Use of Convalescent Plasma: Perception of the Regulatory Framework from a Clinical Perspective (2021) Mohnle P, Humpe A, Boeck M, Gruetzner S, Hackstein H, Offner R, Hildebrandt M Journal article, Review article Continued versus interrupted targeted therapy during metastasis‐directed stereotactic radiotherapy: A retrospective multi‐center safety and efficacy analysis (2021) Kroeze SGC, Fritz C, Schaule J, Blanck O, Kahl KH, Kaul D, Siva S, et al. Journal article Vaccine-Induced Thrombocytopenia with Severe Headache (2021) Salih F, Schoenborn L, Kohler S, Franke C, Moeckel M, Doerner T, Bauknecht HC, et al. Journal article, Letter Melanoma in Pregnancy: CLAUDIUS - a retrospective, multicenter Study to evaluate the Risk of transplacental Transmission to the unborn Child (2021) Gaiser MR, Mueller V, Erdmann M, Buehler B, Dugas-Breit S, Schatton K, Reinhardt L, et al. Conference contribution CTLA4 promoter hypomethylation is a negative prognostic biomarker at initial diagnosis but predicts response and favorable outcome to anti-PD-1 based immunotherapy in clear cell renal cell carcinoma (2021) Klümper N, Ralser DJ, Zarbl R, Schlack K, Schrader AJ, Rehlinghaus M, Hoffmann MJ, et al. Journal article